DekaBank Deutsche Girozentrale’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $889K | Hold |
75,000
| – | – | ﹤0.01% | 805 |
|
|
2025
Q4 | $2.2M | Hold |
75,000
| – | – | ﹤0.01% | 753 |
|
|
2025
Q3 | $1.33M | Hold |
75,000
| – | – | ﹤0.01% | 824 |
|
|
2025
Q2 | $757K | Hold |
75,000
| – | – | ﹤0.01% | 914 |
|
|
2025
Q1 | $569K | Hold |
75,000
| – | – | ﹤0.01% | 952 |
|
|
2024
Q4 | $861K | Hold |
75,000
| – | – | ﹤0.01% | 898 |
|
|
2024
Q3 | $1.54M | Hold |
75,000
| – | – | ﹤0.01% | 809 |
|
|
2024
Q2 | $1.76M | Hold |
75,000
| – | – | ﹤0.01% | 783 |
|
|
2024
Q1 | $1.99M | Sell |
75,000
-3,129
| -4% | -$86.9K | ﹤0.01% | 759 |
|
|
2023
Q4 | $2.5M | Buy |
78,129
+25,000
| +47% | +$718K | 0.01% | 733 |
|
|
2023
Q3 | $1.68M | Buy |
53,129
+3,129
| +6% | +$121K | ﹤0.01% | 781 |
|
|
2023
Q2 | $2.1M | Hold |
50,000
| – | – | ﹤0.01% | 739 |
|
|
2023
Q1 | $1.77M | Buy |
50,000
+10,000
| +25% | +$392K | ﹤0.01% | 743 |
|
|
2022
Q4 | $1.39M | Hold |
40,000
| – | – | ﹤0.01% | 804 |
|
|
2022
Q3 | $2.17M | Buy |
40,000
+7,000
| +21% | +$434K | 0.01% | 691 |
|
|
2022
Q2 | $1.7M | Buy |
33,000
+1,300
| +4% | +$66K | ﹤0.01% | 757 |
|
|
2022
Q1 | $2.29M | Buy |
31,700
+6,600
| +26% | +$559K | 0.01% | 724 |
|
|
2021
Q4 | $2.94M | Buy |
25,100
+600
| +2% | +$75.2K | 0.01% | 688 |
|
|
2021
Q3 | $3.35M | Hold |
24,500
| – | – | 0.01% | 623 |
|
|
2021
Q2 | $3.9M | Sell |
24,500
-2,000
| -8% | -$156K | 0.01% | 584 |
|
|
2021
Q1 | $1.95M | Buy |
26,500
+7,700
| +41% | +$517K | 0.01% | 704 |
|
|
2020
Q4 | $1.02M | Buy |
18,800
+3,100
| +20% | +$113K | ﹤0.01% | 865 |
|
|
2020
Q3 | $335K | Buy |
+15,700
| New | +$327K | ﹤0.01% | 986 |
|
|
2019
Q3 | – | Sell |
-32,600
| Closed | -$496K | – | 1083 |
|
|
2019
Q2 | $496K | Buy |
32,600
+12,600
| +63% | +$198K | ﹤0.01% | 920 |
|
|
2019
Q1 | $624K | Buy |
20,000
+3,700
| +23% | +$55.2K | ﹤0.01% | 862 |
|
|
2018
Q4 | $200K | Sell |
16,300
-3,700
| -19% | -$68.8K | ﹤0.01% | 967 |
|
|
2018
Q3 | $624K | Sell |
20,000
-13,500
| -40% | -$393K | ﹤0.01% | 883 |
|
|
2018
Q2 | $905K | Buy |
33,500
+3,000
| +10% | +$72.7K | 0.01% | 771 |
|
|
2018
Q1 | $645K | Buy |
30,500
+25,900
| +563% | +$637K | ﹤0.01% | 820 |
|
|
2017
Q4 | $76K | Hold |
4,600
| – | – | ﹤0.01% | 1002 |
|
|
2017
Q3 | $76K | Hold |
4,600
| – | – | ﹤0.01% | 1010 |
|
|
2017
Q2 | $75K | Buy |
+4,600
| New | +$64.3K | ﹤0.01% | 986 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
